Determining whether to move forward with licensing a new cell therapy data and clinical workflow management system is a decision that should only be made after knowing all the facts. Decision makers understandably want to see good reasons for implementing new software. Along with costs, tangible and intangible benefits should be presented for consideration.

Hospital Administrators often do not have full visibility into what the Cell Therapy Department has to go through to avoid costly mistakes, document critical key information not in the hospital EHR, and make the best possible decisions. Preparing a well thought-out justification that brings these points to their attention will increase the likelihood of approval.